Synthesis, solution structure analysis and antibody binding of cyclic epitope peptides from glycoprotein D of Herpes simplex virus type I

Biophysical Chemistry

Volumn 106, Issue 2, 2003, Pages 155-171

  Schlosser, Gitta ^a,d   Mezo, Gábor ^a   Kiss, Róbert ^b   Vass, Elemér ^b   Majer, Zsuzsa ^b   Feijlbrief, Matty ^c   Perczel, András ^b   Bosze, Szilvia ^a   Welling Wester, Sytske ^c   Hudecz, Ferenc ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

Antibody binding; Cyclic peptides; HSV gD 1 epitope; NMR; Solution conformation; Thioether bond

Indexed keywords

4 METHYLBENZHYDRYLAMINE; ALANINE; ASPARAGINE; ASPARTIC ACID; BENZHYDRYL DERIVATIVE; CARBENE; CYCLOPEPTIDE; CYSTEINE; EPITOPE; GLYCOPROTEIN D; HOMOCYSTEINE; LYSINE; MONOCLONAL ANTIBODY; PROLINE; PROTEIN ANTIBODY; RESIN; SULFIDE; THIOL GROUP; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ACETYLATION; ALKALINITY; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CHEMICAL BOND; CHLORINATION; CIRCULAR DICHROISM; CYCLIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX VIRUS 1; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE SYNTHESIS; PRECURSOR; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

SIMPLEXVIRUS;

EID: 0141527423     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-4622(03)00187-X     Document Type: Article

References (38)

1. Dyson H.J., Cross K.J., Houghten R.A., Wilson I.A., Wright P.E., Lerner R.A. The immunodominant site of a synthetic immunogen has a conformational preference in water for a type-II reverse turn. Nature. 318:1985;480-486.
2. Dyson R.J., Rance M., Houghten R.A., Lerner R.A., Wright P.E. Folding of immunogenic peptide fragments of proteins in water solution. J. Mol. Biol. 201:1988;161-200.
3. Hruby V.J., Al-Obeidi F., Kazmierski W. Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations. Biochem. J. 268:1990;249-262.
4. Rizo J., Gierasch L.M. Constrained peptides: models of bioactive peptides and protein substructures. Annu. Rev. Biochem. 61:1992;387-418.
5. Saragovi H.U., Fitzpatrick D., Raktabutr A., Nakanishi H., Kahn M., Greene M.I. Design and synthesis of a mimetic from an antibody complementarity-determining region. Science. 253:1991;792-795.
6. Williams W.V., Kieber-Emmons T., VonFeldt J., Greene M.I., Weiner D.B. Design of bioactive peptides based on antibody hypervariable region structures. J. Biol. Chem. 266:1991;5182-5190.
7. Mezo G., Drakopoulou E., Paál V., Rajnavölgyi É., Vita C., Hudecz F. Synthesis and immunological studies of alpha-conotoxin chimera containing an immunodominant epitope from the 268-284 region of HSV gD protein. J. Peptide Res. 55:2000;7-17.
8. Kellenberger E., Mer G., Kellenberger C., Marguerie G., Lefevre J.-F. Solution structure of a conformationally constrained Arg-Gly-Asp-like motif inserted into the α/β scaffold of leiurotoxin I. Eur. J. Biochem. 260:1999;810-817.
9. Hollósi M., Ismail A.A., Mantsch H.H., Penke B., Váradi I.G., Tóth G.K., et al. Conformational and functional properties of peptides covering the intersubunit region of influenza virus hemagglutinin. Eur. J. Biochem. 206:1992;421-425.
10. Vu H.M., Myers D., De Lorimier R., Matthews T.J., Moody M.A., Heinly C., et al. Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from Human Immunodeficiency Virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodies. J. Virol. 73:1999;746-750.
11. Li S.-Y., Lee J.-H., Lee W., Yoon C.-J., Baik J.-H., Lim S.-K. Type I β-turn conformation is important for biological activity of the melanocyte-stimulating hormone analogues. Eur. J. Biochem. 265:1999;430-440.
12. Kapurniotu A., Kayed R., Taylor J.W., Voelter W. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues. Eur. J. Biochem. 265:1999;606-618.
13. Leprince J., Oulyadi H., Vaudry D., Masmoudi O., Gandolfo P., Patte C., et al. Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Eur. J. Biochem. 268:2001;6045-6057.
14. Gould A.R., Mabbutt B.C., Llewellyn L.E., Goss N.H., Norton R.S. Linear and cyclic peptide analogues of the polypeptide cardiac stimulant, anthopleurin-A. 1H-NMR and biological activity studies. Eur. J. Biochem. 206:1992;641-651.
15. Gurrath M., Muller G., Kessler H., Aumailley M., Timpl R. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides. Eur. J. Biochem. 1992:1992;911-921.
16. Kates S.A., Solé N.A., Albericio F., Barany G. Basava C., Anantharamiak G.M. Peptides: Design, Synthesis and Biological Activity. 1994;39-58 Birkhauser, Boston.
17. Mezo G., Majer Z., Valero M.-L., Andreu D., Hudecz F. Synthesis of cyclic Herpes simplex virus peptides containing 281-284 epitope of glycoprotein D-1 in endo- or exo-position. J. Peptide Sci. 5:1999;272-282.
18. D. Andreu, F. Albericio, N.A. Solé, M.C. Munson, M. Ferrer, G. Barany, Methods in Molecular Biology 35, Peptide Synthesis Protocols, in: M.W. Pennington, B.M. Dunn (Eds.), 1994, pp. 91-168.
19. Pallin T.D., Tam J.P. Cyclisation of totally unprotected peptides in aqueous solution by oxime formation. J. Chem. Soc. Chem. Commun. 1995;2021-2022.
20. Botti P., Pallin T.D., Tam J.P. Cyclic peptides from linear unprotected peptide precursors through thiazolidine formation. J. Am. Chem. Soc. 118: 1996;10 018-10 024.
21. Robey F.A., Fields R.L. Automated synthesis of N-bromoacetyl-modified peptides for the preparation of synthetic peptide polymers, peptide-protein conjugates and cyclic peptides. Anal. Biochem. 177:1989;373-377.
22. Cohen G.H., Ponce DeLeon M., Nichols C. Isolation of a Herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody. J. Virol. 10:1972;1021-1030.
23. Para M.F., Parish M.L., Noble G., Spear P.G. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. J. Virol. 55:1985;483-488.
24. Welling-Wester S., Scheffer A.-J., Welling G.W. B and T cell epitopes of glycoprotein D of Herpes simplex virus type 1. Microbiol. Immunol. 76:1991;59-68.
25. Welling-Wester S., Feijlbrief M., Koedijk D.G., Drijfhout J.W., Weijer W.J., Scheffer A.J., et al. Analogues of peptide 9-21 of glycoprotein D of Herpes simplex virus and their binding to group VII monoclonal antibodies. Arch. Virol. 138:1994;331-340.
26. Weijer W.J., Drijfhout J.W., Geerlings H.J., Bloemhoff J., Feijlbrief M., Bos C.A., et al. Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro. J. Virol. 62:1988;501-510.
27. Williamson M.P., Handa B.K., Hall M.J. Secondary structure of a Herpes simplex virus glycoprotein D antigenic domain. Int. J. Peptide Protein Res. 27:1986;562-568.
28. Williamson M.P., Hall M.J., Handa B.K. 1H-NMR assignment and secondary structure of a Herpes simplex virus glycoprotein D-1 antigenic domain. Eur. J. Biochem. 158:1986;527-536.
29. Heber-Katz E., Hollósi M., Dietzschold B., Hudecz F., Fasman G.D. The T cell response to the glycoprotein D of the Herpes simplex virus: the significance of antigen conformation. J. Immunol. 135:1985;1385-1390.
30. Ivanov B.B., Robey A.F. Effective use of free thiols as scavengers for HF cocktails to deprotect bromo- and chloroacetylated synthetic peptides. Peptide Res. 9:1996;305-307.
31. Kolodny N., Robey F.A. Conjugation of synthetic peptides to proteins: quantitation from S-carboxymethylcysteine released upon acid hydrolysis. Anal. Biochem. 187:1990;136-140.
32. Azam F., Bladon C.M. Synthetic approaches to macromolecular models for ion channel proteins. Tetrahedron Lett. 39:1998;6377-6380.
33. Jones D.S., Gamino C.A., Randow M.E., Victoria E.J., Yu L., Coutts S.M. Synthesis of a cyclic-thioether peptide which binds anti-cardiolipin antibodies. Tetrahedron Lett. 39:1998;6107-6110.
34. Roberts K.D., Lambert J.N., Ede N.J., Bray A.M. Efficient synthesis of thioether-based cyclic peptide libraries. Tetrahedron Lett. 39:1998;8357-8360.
35. Fotouhi N., Joshi P., Tilley J.W., Rowan K., Schwinge V., Wolitzky B. Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists. Bioorg. Med. Chem. Lett. 10:2000;1167-1169.
36. König W., Geiger R. Eine neue Methode zur Synthese von Peptiden: Aktivierung der Carboxylgruppe mit Dicyclohexyl-carbidiimid unter Zusatz von 1-Hydroxy-benzotriazolen. Chem. Ber. 103:1970;788-798.
37. Kaiser E., Colescott R.L., Bossinger C.D., Cook P.I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34:1970;595-598.
38. Krchnak V., Vagner J., Safar P., Lebl M. Non-invasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator. Collect. Czech. Chem. Commun. 53:1988;2542-2548.